Skip to main content
SpringerLink
Log in

Place of Surgical Resection in the Treatment Strategy for Gastrointestinal Neuroendocrine Tumors

  • Chapter
  • First Online:
Management of Neuroendocrine Tumors of the Pancreas and Digestive Tract

  • 1281 Accesses

Abstract

Neuroendocrine tumors (NETs) of the digestive tract are usually slow-growing neoplasms carrying an overall favorable prognosis. Even if most of patients have metastatic or locally advanced tumors, surgery, from resection to transplantation, remains the only potential curative option for these patients and should always be considered. Nevertheless, because of the very few randomized controlled trials available, the optimal place of surgery within a global treatment strategy remains controversial.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 39.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 54.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 54.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Gurusamy KS, Ramamoorthy R, Sharma D et al (2009) Liver resection versus other treatments for neuroendocrine tumours in patients with resectable liver metastases. Cochrane Database Syst Rev CD007060

    Google Scholar 

  2. Cho CS, Labow DM, Tang L et al (2008) Histologic grade is correlated with outcome after resection of hepatic neuroendocrine neoplasms. Cancer 113:126–134

    Article  PubMed  Google Scholar 

  3. Sarmiento JM, Heywood G, Rubin J et al (2003) Surgical treatment of neuroendocrine metastases to the liver: a plea for resection to increase survival. J Am Coll Surg 197:29–37

    Article  PubMed  Google Scholar 

  4. McKenzie S, Lee W, Artinyan A et al (2010) Surgical resection and multidisciplinary care for primary and metastatic pancreatic islet cell carcinomas. J Gastrointest Surg 14:1796–1803

    Article  PubMed  Google Scholar 

  5. Elias D, Lasser P, Ducreux M et al (2003) Liver resection (and associated extrahepatic resections) for metastatic well-differentiated endocrine tumors: a 15-year single center prospective study. Surgery 133:375–382

    Article  PubMed  Google Scholar 

  6. Osborne DA, Zervos EE, Strosberg J et al (2006) Improved outcome with cytoreduction versus embolization for symptomatic hepatic metastases of carcinoid and neuroendocrine tumors. Ann Surg Oncol 13:572–581

    Article  PubMed  Google Scholar 

  7. Sarmiento JM, Que FG (2003) Hepatic surgery for metastases from neuroendocrine tumors. Surg Oncol Clin N Am 12:231–242

    Article  PubMed  Google Scholar 

  8. Fendrich V, Langer P, Celik I et al (2006) An aggressive surgical approach leads to long-term survival in patients with pancreatic endocrine tumors. Ann Surg 244:845–851; discussion 852–843

    Google Scholar 

  9. Schurr PG, Strate T, Rese K et al (2007) Aggressive surgery improves long-term survival in neuroendocrine pancreatic tumors: an institutional experience. Ann Surg 245:273–281

    Article  PubMed Central  PubMed  Google Scholar 

  10. Que FG, Nagorney DM, Batts KP et al (1995) Hepatic resection for metastatic neuroendocrine carcinomas. Am J Surg 169:36–42; discussion 42–33

    Google Scholar 

  11. Hill JS, McPhee JT, McDade TP et al (2009) Pancreatic neuroendocrine tumors: the impact of surgical resection on survival. Cancer 115:741–751

    Article  PubMed  Google Scholar 

  12. Chu QD, Hill HC, Douglass HO Jr et al (2002) Predictive factors associated with long-term survival in patients with neuroendocrine tumors of the pancreas. Ann Surg Oncol 9:855–862

    Article  PubMed  Google Scholar 

  13. Grfnbech JE, Søreide O, Bergan A (1992) The role of respective surgery in the treatment of the carcinoid syndrome. Scand J Gastroenterol 27:433–437

    Article  Google Scholar 

  14. Han SL, Cheng J, Zhou HZ et al (2010) Surgically treated primary malignant tumor of small bowel: a clinical analysis. World J Gastroenterol 16:1527–1532

    Article  PubMed Central  PubMed  Google Scholar 

  15. Hellman P, Lundström T, Öhrvall U, Eriksson B, Skogseid B, Öberg K et al (2002) Effect of surgery on the outcome of midgut carcinoid disease with lymph node and liver metastases. World J Surg 26:991–997

    Article  PubMed  Google Scholar 

  16. Landerholm K, Zar N, Andersson RE et al (2011) Survival and prognostic factors in patients with small bowel carcinoid tumour Brit J Surg 98:1617–1624

    CAS  Google Scholar 

  17. Nave H, Mossinger E, Feist H et al (2001) Surgery as primary treatment in patients with liver metastases from carcinoid tumors: a retrospective, unicentric study over 13 years. Surgery 129:170–175

    Article  CAS  PubMed  Google Scholar 

  18. Søreide O, Berstad T, Bakka A et al (1992) Surgical treatment as a principle in patients with advanced abdominal carcinoid tumors. Surgery 111:48–54

    PubMed  Google Scholar 

  19. Dromain C, de Baere T, Lumbroso J et al (2005) Detection of liver metastases from endocrine tumors: a prospective comparison of somatostatin receptor scintigraphy, computed tomography, and magnetic resonance imaging. J Clin Oncol 23:70–78

    Article  PubMed  Google Scholar 

  20. d’Assignies G, Fina P, Bruno O, Vullierme MP, Tubach F, Paradis V, Sauvanet A, Ruszniewski P, Vilgrain V (2013) High sensitivity of diffusion-weighted MRI for the detection of liver metastases from neuroendocrine tumors compared with T2-weighted and dynamic gadolinium-enhanced MRI, using surgical and histological findings as a standard of reference. Radiology Mar 2013

    Google Scholar 

  21. Hakim FA, Alexander JA, Huprich JE et al (2011) CT-enterography may identify small bowel tumors not detected by capsule endoscopy: eight years experience at Mayo Clinic Rochester. Dig Dis Sci 56(10):2914–2919

    Article  PubMed  Google Scholar 

  22. Masselli G, Polettini E, Casciani E et al (2009) Small-bowel neoplasms: prospective evaluation of MR enteroclysis. Radiology 251(3):743–750

    Article  PubMed  Google Scholar 

  23. Schiesser M, Veit-Haibach P, Muller MK et al (2010) Value of combined 6-[18F] fluorodihydroxyphenylalanine PET/CT for imaging of neuroendocrine tumours. Br J Surg 97:691–697

    Article  CAS  PubMed  Google Scholar 

  24. Abgral R, Leboulleux S, Deandreis D et al (2011) Performance of (18) fluorodeoxyglucose-positron emission tomography and somatostatin receptor scintigraphy for high Ki67 (>/=10%) well-differentiated endocrine carcinoma staging. J Clin Endocrinol Metab 96:665–671

    Article  CAS  PubMed  Google Scholar 

  25. Dudczak R, Traub-Weidinger T (2010) PET and PET/CT in endocrine tumours. Eur J Radiol 73:481–493

    Article  PubMed  Google Scholar 

  26. Masui T, Doi R, Ito T et al (2010) Diagnostic value of (18)F-fluorodeoxyglucose positron emission tomography for pancreatic neuroendocrine tumors with reference to the World Health Organization classification. Oncol Lett 1(1):155–159

    PubMed Central  PubMed  Google Scholar 

  27. McLean A (2004) Endoscopic ultrasound in the detection of pancreatic islet cell tumours. Cancer Imaging 4:84–91

    Article  PubMed Central  PubMed  Google Scholar 

  28. Kloppel G, Rindi G, Perren A et al (2010) The ENETS and AJCC/UICC TNM classifications of the neuroendocrine tumors of the gastrointestinal tract and the pancreas: a statement. Virchows Arch 456:595–597

    Article  PubMed  Google Scholar 

  29. Rindi G, Arnold R, Bosman F et al (2010) Nomenclature and classification of neuroendocrine neoplasms of the digestive system. In: Bosman F, Carneiro F, Hruban R et al (eds) WHO classification of tumours of the digestive system, international agency for research on cancer 2010

    Google Scholar 

  30. Soblin L, Gospodarowicz M, Wittekind C (2009) TNM classification of malignant tumours, 7th edn. Wiley, New York

    Google Scholar 

  31. Dolcetta-Capuzzo A, Villa V, Albarello L et al (2012) Gastroenteric neuroendocrine neoplasms classification: comparison of prognostic models. Cancer 119(1):36–44

    Google Scholar 

  32. Norlen O, Hessman O, Stalberg P et al (2010) Prophylactic cholecystectomy in midgut carcinoid patients. World J Surg 34:1361–1367

    Article  PubMed  Google Scholar 

  33. Wagnetz U, Jaskolka J, Yang P et al (2010) Acute ischemic cholecystitis after transarterial chemoembolization of hepatocellular carcinoma: incidence and clinical outcome. J Comput Assist Tomogr 34:348–353

    Article  PubMed  Google Scholar 

  34. Chua HK, Sondenaa K, Tsiotos GG et al (2004) Concurrent vs. staged colectomy and hepatectomy for primary colorectal cancer with synchronous hepatic metastases. Dis Colon Rectum 47:1310–1316

    Article  PubMed  Google Scholar 

  35. Borch K, Ahren B, Ahlman H et al (2005) Gastric carcinoids: biologic behavior and prognosis after differentiated treatment in relation to type. Ann Surg 242:64–73

    Article  PubMed Central  PubMed  Google Scholar 

  36. Kulke MH (2003) Neuroendocrine tumours: clinical presentation and management of localized disease. Cancer Treat Rev 29(5):363–370

    Article  CAS  PubMed  Google Scholar 

  37. Akerström G, Hellman P (2007) Surgery on neuroendocrine tumours. Best Pract Res Clin Endocrinol Metab 21(1):87–109

    Article  PubMed  Google Scholar 

  38. Kim BS, Oh ST, Yook JH et al (2010) Typical carcinoids and neuroendocrine carcinomas of the stomach: differing clinical courses and prognoses. Am J Surg 200:328–333

    Article  PubMed  Google Scholar 

  39. Modlin IM, Lye KD, Kidd M (2003) Carcinoid tumors of the stomach. Surg Oncol 12:153–172

    Article  PubMed  Google Scholar 

  40. Service FJ, McMahon MM, O’Brien PC et al (1991) Functioning insulinoma–incidence, recurrence, and long-term survival of patients: a 60-year study. Mayo Clin Proc 66:711–719

    Article  Google Scholar 

  41. Crippa S, Zerbi A, Boninsegna L et al (2012) Surgical management of insulinomas: short- and long-term outcomes after enucleations and pancreatic resections. Arch Surg 147:261–266

    Article  PubMed  Google Scholar 

  42. Nesje LB, Varhaug JE, Husebye ES et al (2002) Endoscopic ultrasonography for preoperative diagnosis and localization of insulinomas. Scand J Gastroenterol 37:732–737

    Article  CAS  PubMed  Google Scholar 

  43. McLean AM, Fairclough PD (2005) Endoscopic ultrasound in the localisation of pancreatic islet cell tumours. Best Pract Res Clin Endocrinol Metab 19:177–193

    Article  CAS  PubMed  Google Scholar 

  44. Daneshvar K, Grenacher L, Mehrabi A et al (2011) Preoperative tumor studies using MRI or CT in patients with clinically suspected insulinoma. Pancreatology 11:487–494

    Article  PubMed  Google Scholar 

  45. Zhang T, Mu Y, Qu L et al (2012) Accurate combined preoperative localization of insulinomas aid the choice for enucleation: a single institution experience over 25 years. Hepatogastroenterology 59:1282–1285

    Article  PubMed  Google Scholar 

  46. Nikfarjam M, Warshaw AL, Axelrod L et al (2008) Improved contemporary surgical management of insulinomas: a 25-year experience at the Massachusetts general hospital. Ann Surg 247:165–172

    Article  PubMed Central  PubMed  Google Scholar 

  47. Hu M, Zhao G, Luo Y et al (2011) Laparoscopic versus open treatment for benign pancreatic insulinomas: an analysis of 89 cases. Surg Endosc 25:3831–3837

    Article  PubMed  Google Scholar 

  48. Crippa S, Boninsegna L, Partelli S et al (2010) Parenchyma-sparing resections for pancreatic neoplasms. J Hepatobiliary Pancreat Sci 17:782–787

    Article  PubMed  Google Scholar 

  49. Crippa S, Bassi C, Salvia R et al (2007) Enucleation of pancreatic neoplasms. Br J Surg 94:1254–1259

    Article  CAS  PubMed  Google Scholar 

  50. O’Toole D, Salazar R, Falconi M et al (2006) Rare functioning pancreatic endocrine tumors. Neuroendocrinology 84:189–195

    Article  PubMed  Google Scholar 

  51. Jensen RT et al (2008) Inherited pancreatic endocrine tumor syndromes: advances in molecular pathogenesis, diagnosis, management, and controversies. Cancer 113(S7):1807–1843

    Article  PubMed Central  PubMed  Google Scholar 

  52. Bettini R, Partelli S, Boninsegna L et al (2011) Tumor size correlates with malignancy in nonfunctioning pancreatic endocrine tumor. Surgery 150:75–82

    Article  PubMed  Google Scholar 

  53. Haynes AB, Deshpande V, Ingkakul T et al (2011) Implications of incidentally discovered, nonfunctioning pancreatic endocrine tumors: short-term and long-term patient outcomes. Arch Surg 146:534–538

    Article  PubMed Central  PubMed  Google Scholar 

  54. Kuvibidila S, Baliga BS, Gardner R et al (2005) Differential effects of hydroxyurea and zileuton on interleukin-13 secretion by activated murine spleen cells: implication on the expression of vascular cell adhesion molecule-1 and vasoocclusion in sickle cell anemia. Cytokine 30:213–218

    Article  CAS  PubMed  Google Scholar 

  55. www.enets.com

  56. Eriksson B, Kloppel G, Krenning E et al (2008) Consensus guidelines for the management of patients with digestive neuroendocrine tumors–well-differentiated jejunal-ileal tumor/carcinoma. Neuroendocrinology 87:8–19

    Article  CAS  PubMed  Google Scholar 

  57. Modlin IM, Lye KD, Kidd M (2003) A 5-decade analysis of 13,715 carcinoid tumors. Cancer 97:934–959

    Article  PubMed  Google Scholar 

  58. Bilimoria KY, Bentrem DJ, Wayne JD et al (2009) Small bowel cancer in the United States: changes in epidemiology, treatment, and survival over the last 20 years. Ann Surg 249:63–71

    Article  PubMed  Google Scholar 

  59. Le Roux C, Lombard-Bohas C, Delmas C et al (2011) Groupe d’étude des Tumeurs Endocrines (GTE). Relapse factors for ileal neuroendocrine tumours after curative surgery: a retrospective French multicentre study. Dig Liver Dis 43(10):828–833

    Article  PubMed  Google Scholar 

  60. Moertel CG, Weiland LH, Nagorney DM et al (1987) Carcinoid tumor of the appendix: treatment and prognosis. N Engl J Med 317:1699–1701

    Article  CAS  PubMed  Google Scholar 

  61. Mandair D, Caplin ME (2012) Colonic and rectal NET’s. Best Pract Res Clin Gastroenterol 26(6):775–789

    Article  PubMed  Google Scholar 

  62. Choi CW, Kang DH, Kim HW et al (2013) Comparison of endoscopic resection therapies for rectal carcinoid tumor: endoscopic submucosal dissection versus endoscopic mucosal resection using band ligation. J Clin Gastroenterol 47(5):432–436

    Article  PubMed  Google Scholar 

  63. Lee SH, Park SJ, Kim HH et al (2012) Endoscopic resection for rectal carcinoid tumors: comparison of polypectomy and endoscopic submucosal resection with band ligation. Clin Endosc 45(1):89–94

    Article  PubMed Central  PubMed  Google Scholar 

  64. Chen et al (2012) Molecular pathology of pancreatic neuroendocrine tumors. J Gastrointest Oncol 3(3):182–188

    PubMed Central  PubMed  Google Scholar 

  65. Triponez F, Goudet P, Dosseh D et al (2006) Is surgery beneficial for MEN1 patients with small (< or = 2 cm), nonfunctioning pancreaticoduodenal endocrine tumor? An analysis of 65 patients from the GTE. World J Surg 30:654–662; discussion 663–654

    Google Scholar 

  66. O’Riordain DS, O’Brien T, van Heerden JA et al (1994) Surgical management of insulinoma associated with multiple endocrine neoplasia type I. World J Surg 18:488–493; discussion 493–484

    Google Scholar 

  67. de Wilde RF, Edil BH, Hruban RH et al (2012) Well-differentiated pancreatic neuroendocrine tumors: from genetics to therapy. Nat Rev Gastroenterol Hepatol 9(4):199–208

    Article  PubMed Central  PubMed  Google Scholar 

  68. Tamura K, Nishimori I, Ito T et al (2010) Diagnosis and management of pancreatic neuroendocrine tumor in von Hippel–Lindau disease. World J Gastroenterol 16(36):4515–4518

    Article  PubMed Central  PubMed  Google Scholar 

  69. Blansfield JA, Choyke L, Morita SY et al (2007) Clinical, genetic and radiographic analysis of 108 patients with von Hippel–Lindau disease (VHL) manifested by pancreatic neuroendocrine neoplasms (PNETs). Surgery 142:814–818; discussion 818.e1–818.e2

    Google Scholar 

  70. Landry CS, Waguespack SG, Perrier ND (2009) Surgical management of nonmultiple endocrine neoplasia endocrinopathies: state-of-the-art review. Surg Clin N Am 89:1069–1089

    Article  PubMed  Google Scholar 

  71. De Palma GD, Masone S, Siciliano S et al (2010) Endocrine carcinoma of the major papilla: report of two cases and review of the literature. Surg Oncol 19(4):235–242

    Article  PubMed  Google Scholar 

  72. Klein A, Clemens J, Cameron J (1989) Periampullary neoplasms in von Recklinghausen’s disease. Surgery 106(5):815–819

    CAS  PubMed  Google Scholar 

  73. Makhlouf HR, Burke AP, Sobin LH (1999) Carcinoid tumors of the ampulla of Vater: a comparison with duodenal carcinoid tumors. Cancer 85(6):1241e9

    Google Scholar 

  74. Lodish MB, Stratakis CA (2010) Endocrine tumours in neurofibromatosis type 1, tuberous sclerosis and related syndromes. Best Pract Res Clin Endocrinol Metab 24(3):439–449

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  75. Elias D, Lefevre JH, Duvillard P et al (2010) Hepatic metastases from neuroendocrine tumors with a “thin slice” pathological examination: they are many more than you think. Ann Surg 251:307–310

    Article  PubMed  Google Scholar 

  76. Panzuto F, Nasoni S, Falconi M et al (2005) Prognostic factors and survival in endocrine tumor patients: comparison between gastrointestinal and pancreatic localization. Endocr Relat Cancer 12:1083–1092

    Article  PubMed  Google Scholar 

  77. Bilimoria KY, Talamonti MS, Tomlinson JS et al (2008) Prognostic score predicting survival after resection of pancreatic neuroendocrine tumors: analysis of 3851 patients. Ann Surg 247:490–500

    Article  PubMed  Google Scholar 

  78. Modlin IM, Sandor A (1997) An analysis of 8305 cases of carcinoid tumors. Cancer 79:813–829

    Article  CAS  PubMed  Google Scholar 

  79. Kianmanesh R, Sauvanet A, Hentic O et al (2008) Two-step surgery for synchronous bilobar liver metastases from digestive endocrine tumors: a safe approach for radical resection. Ann Surg 247:659–665

    Article  PubMed  Google Scholar 

  80. Bacchetti S, Bertozzi S, Londero AP et al (2013) Surgical treatment and survival in patients with liver metastases from neuroendocrine tumors: a meta-analysis of observational studies. Int J Hepatol 2013:235040

    Article  PubMed Central  PubMed  Google Scholar 

  81. Le Treut YP, Gregoire E, Belghiti J et al (2008) Predictors of long-term survival after liver transplantation for metastatic endocrine tumors: an 85-case French multicentric report. Am J Transplant 8:1205–1213

    Article  PubMed  Google Scholar 

  82. Gedaly R, Daily MF, Davenport D et al (2011) Liver transplantation for the treatment of liver metastases from neuroendocrine tumors: an analysis of the UNOS database. Arch Surg 146:953–958

    Article  PubMed  Google Scholar 

  83. Le Treut YP et al (2013) Liver transplantation for neuroendocrine tumors in Europe-results and trends in patient selection: a 213-case European liver transplant registry study. Ann Surg 257(5):807–815

    Article  PubMed  Google Scholar 

  84. Nguyen NT, Harring TR, Goss JA, O’Mahony CA (2011) Neuroendocrine liver metastases and orthotopic liver transplantation: the US experience. Int J Hepatol 2011:742890

    Article  PubMed Central  PubMed  Google Scholar 

  85. Lahat G, Ben Haim M, Nachmany I et al (2009) Pancreatic incidentalomas: high rate of potentially malignant tumors. J Am Coll Surg 209:313–319

    Article  PubMed  Google Scholar 

  86. Piani C, Franchi GM, Cappelletti C et al (2008) Cytological Ki-67 in pancreatic endocrine tumours: an opportunity for pre-operative grading. Endocr Relat Cancer 15:175–181

    Article  PubMed  Google Scholar 

  87. Figueiredo FA, Giovannini M, Monges G et al (2009) EUS-FNA predicts 5-year survival in pancreatic endocrine tumors. Gastrointest Endosc 70:907–914

    Article  PubMed  Google Scholar 

  88. d’Assignies G, Couvelard A, Bahrami S et al (2009) Pancreatic endocrine tumors: tumor blood flow assessed with perfusion CT reflects angiogenesis and correlates with prognostic factors. Radiology 250:407–416

    Article  PubMed  Google Scholar 

  89. Wang Y, Chen ZE, Yaghmai V et al (2011) Diffusion-weighted MR imaging in pancreatic endocrine tumors correlated with histopathologic characteristics. J Magn Reson Imaging 33:1071–1079

    Article  PubMed  Google Scholar 

  90. Garin E, Le Jeune F, Devillers A et al (2009) Predictive value of 18F-FDG PET and somatostatin receptor scintigraphy in patients with metastatic endocrine tumors. J Nucl Med 50:858–864

    Article  CAS  PubMed  Google Scholar 

  91. Tonelli F, Fratini G, Nesi G et al (2006) Pancreatectomy in multiple endocrine neoplasia type 1-related gastrinomas and pancreatic endocrine neoplasias. Ann Surg 244:61–70

    Article  PubMed Central  PubMed  Google Scholar 

  92. Máthé Z, Tagkalos E, Paul A et al (2011) Liver transplantation for hepatic metastases of neuroendocrine pancreatic tumors: a survival-based analysis. Transplantation 91:575–582

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Surgery, Hospital Beaujon, 100 Boulevard du Général Leclerc, Clichy, 92118, Cedex, France

    Jacques Belghiti

  2. Departments of Hepato-Pancreato-Biliary Surgery and Transplantation, Beaujon Hospital, Assistance Publique Hôpitaux de Paris, Clichy, France

    Sébastien Gaujoux, Marleny Figueiredo, David Fuks & Alain Sauvanet

  3. University Denis Diderot-Paris 7, Paris, France

    Sébastien Gaujoux, Marleny Figueiredo, David Fuks & Alain Sauvanet

Authors
  1. Jacques Belghiti
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Sébastien Gaujoux
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Marleny Figueiredo
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. David Fuks
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Alain Sauvanet
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Jacques Belghiti .

Editor information

Editors and Affiliations

  1. Medical Oncology, Bichat-Beaujon University Hospitals, Clichy cedex, France

    Eric Raymond

  2. Bichat-Beaujon University Hospitals Medical Oncology, Clichy cedex, France

    Sandrine Faivre

  3. Pancreatology, Bichat-Beaujon University Hospitals Gastroenterology and, Clichy cedex, France

    Philippe Ruszniewski

Rights and permissions

Reprints and permissions

Copyright information

© 2014 Springer-Verlag France

About this chapter

Cite this chapter

Belghiti, J., Gaujoux, S., Figueiredo, M., Fuks, D., Sauvanet, A. (2014). Place of Surgical Resection in the Treatment Strategy for Gastrointestinal Neuroendocrine Tumors. In: Raymond, E., Faivre, S., Ruszniewski, P. (eds) Management of Neuroendocrine Tumors of the Pancreas and Digestive Tract. Springer, Paris. https://doi.org/10.1007/978-2-8178-0430-9_6

Download citation

  • DOI: https://doi.org/10.1007/978-2-8178-0430-9_6

  • Published:

  • Publisher Name: Springer, Paris

  • Print ISBN: 978-2-8178-0429-3

  • Online ISBN: 978-2-8178-0430-9

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation